“…Numerous high-performance liquid chromatography (HPLC) methods with fluorescence (FL) detection (Bardot, Vest, Renard, & Renaudeau, 2005;De Smet et al, 2009;Hemanth Kumar & Ramachandran, 2009;Muchohi et al, 2011;Neckel et al, 2002;Sousa, Alves, Campos, Fortuna, & Falcão, 2013;Watabe et al, 2010) and liquid chromatography-tandem mass spectrometry methods (LC-MS/ MS) (Ji et al, 2006;Pranger, Alffenaar, Wessels, Greijdanus, & Uges, 2010;Zander et al, 2015) have been published for the quantification of the selected FQs in human plasma or serum. However, only a few HPLC methods with ultraviolet (UV) detection have been described for the simultaneous quantification two or more FQs (Cavazos-Rocha, Carmona-Alvarado, Vera-Cabrera, Waksman- de-Torres, & Salazar-Cavazos, 2014;Helmy, 2013;Khan et al, 2016;Locatelli et al, 2015;Locatelli, Cifelli, Carlucci, & Romagnoli, 2016;Mannemala & Kannappan, 2016;Srinivas, Narasu, Shankar, & Mullangi, 2008). To our best knowledge, no HPLC-UV method has been published for the simultaneous quantification of LEV, PEF, CIP and MOX in human plasma or serum.…”